Label: SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL SCALP BUTTER CREAM- sulfur, salicylic acid ointment

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 21, 2023

If you are a consumer or patient please visit this version.

  • Drug Facts

  • Active Ingredient

    Sulfur, 5%

    Salicylic Acid, 3%

    Purpose

    Antidandruff

  • Use

    • relieves the itching and scaling associated with dandruff
  • Warnings

    For external use only

    When using this product

    avoid contact with eyes. If contact occurs rinse eyes thoroughly with water.

    Stop use and consult a doctor if

    • condition worsens or does not improve after regular use as directed.
    • HAIR IS FLAMMABLE. Flammability is increased by product build-up. Keep hair away from sparks, flame, extreme heat or lit tobacco.

    Keep out of reach of children.

    If swallowed, get medical help or call a Poison Control Center right away.

  • Directions

    • Apply a small amount to the scalp one to four times daily or as directed by a doctor.
  • Inactive Ingredients

    Petrolatum, Mineral Oil, Tribehenin, Arachidyl Propionate, Polysorbate 20, Fragrance

  • Package Labeling:

    3

  • INGREDIENTS AND APPEARANCE
    SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL SCALP BUTTER CREAM 
    sulfur, salicylic acid ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-035
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR50 mg  in 1 g
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID30 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    PETROLATUM (UNII: 4T6H12BN9U)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    TRIBEHENIN (UNII: 8OC9U7TQZ0)  
    ARACHIDYL PROPIONATE (UNII: QV5DAH3MSB)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:12022-035-0099 g in 1 JAR; Type 0: Not a Combination Product01/01/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM03201/01/2020
    Labeler - J. Strickland and Co. (007023112)